Journal
FRONTIERS IN ENDOCRINOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.815995
Keywords
prolactin; metabolic-associated fatty liver disease; type 2 diabetes; gender-specific difference; liver fibrosis
Categories
Funding
- National Key R&D Program of China [2018YFC1314100]
- Shanghai Committee of Science and Technology of China [18411951803, 17DZ1910603]
- National Natural Science Foundation of China [81970677]
- Shanghai Pujiang Program [2019PJD040, 2018PJD038]
- New Exploration of Blood Glucose Management Mode in Patients with Diabetes Mellitus in Chongming Area of Shanghai [CKY2018-19]
Ask authors/readers for more resources
In this study, serum prolactin levels were found to have a J-shaped association with the risk of metabolic-associated fatty liver disease (MAFLD) and liver fibrosis in females with type 2 diabetes mellitus (T2DM), indicating a gender-specific relevance of prolactin to MAFLD and its progression.
BackgroundMetabolic-associated fatty liver disease (MAFLD) has become a worldwide epidemic. Prolactin (PRL), a pituitary hormone, has been linked to MAFLD. As a result, we set out to look into the relationship between serum PRL and the risk of MAFLD in patients with type 2 diabetes mellitus (T2DM). MethodsA total of 724 adults with T2DM were enrolled and categorized as MAFLD and non-MAFLD groups. Anthropometric data, biochemical parameters, and serum PRL levels were collected. Liver steatosis and fibrosis were assessed using FibroScan. Patients were stratified into normal PRL (NP) and high PRL (HP) groups and divided into four groups based on serum PRL quartiles. Multivariate logistic regression analysis was performed to evaluate the association between serum PRL and MAFLD risk. ResultsFemale but not male patients with MAFLD, liver steatosis, and fibrosis had significantly lower PRL levels in the NP group but higher PRL levels in the HP group than their counterparts. The proportions of MAFLD, liver steatosis, and fibrosis were significantly decreased in the NP group but increased in the HP group across the PRL quartiles in females but not in males. After multivariate adjustment, the adjusted ORs (AORs) and 95% CI for MAFLD among females were 18.165 (3.425-96.336), 1.784 (0.658-5.002), 1.744 (0.608-4.832), and 1.00 (reference) in the NP group (Q1-Q4, P-trend < 0.001) and 1.00 (reference), 11.098 (1.819-110.356), 15.225 (1.996-116.112), and 18.211 (2.579-128.568) in the HP group (Q1-Q4, P-trend = 0.020). Such associations were also found between serum PRL and liver fibrosis in females but not in males. ConclusionWe observed a J-shaped association between serum PRL and the risk of MAFLD and liver fibrosis in females but not in males with T2DM, indicating that PRL may be relevant to MAFLD and its progression in a gender-specific manner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available